ACUT — ACCUSTEM SCIENCES Share News
0.000.00%
Last trade - 00:00Brief: Accustem Sciences, Inc. Signs Agreement To Access Blood Samples From Lung Cancer Screening Trial To Expedite Msc Commercialization Plan
Brief: Accustem Sciences, Inc. And Emeritusdx Announce Joint Product Development Agreement And Strategic Partnership
Brief: Accustem Sciences Ltd Applies To List Common Stock On Nasdaq Under Symbol “ACUT” - SEC Filing